2025 annual financial data

CollPlant Biotechnologies 2025 Net margin

Direct answer

Net margin was -484.56%.

Operating income was -11,483,000 USD and net income was -11,489,000 USD.
Operating cash flow was -9,419,000 USD.

Get free CollPlant Biotechnologies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2,371,000 USD
Operating income
-11,483,000 USD
Net income
-11,489,000 USD
Operating cash flow
-9,419,000 USD